Skip to main content
SpringerLink
Log in

Role of proton pump inhibitors in the prevention of NSAID-induced ulcers now emerging

  • New drugs and disease management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Brown GJE, Yeomans ND. Prevention of the gastrointestinal adverse effects of nonsteroidal anti-inflammatory drugs: the role of proton pump inhibitors. Drug Saf 1999 Dec; 21(6): 503–12

    Article  PubMed  CAS  Google Scholar 

  2. British National Formulary. No. 39. London: The Pharmaceutical Press, 2000 Mar: 39-42

  3. Drug Topics Red Book 1999. Montvale (NJ): Medical Economics Company, 1999: 272-3, 507, 604

  4. Yeomans ND, Tulassay Z, Juhász L, et al. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1998; 338: 719–26

    Article  PubMed  CAS  Google Scholar 

  5. Hawkey CJ, Karrasch JA, Szczepañski L, et al. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1998; 338: 727–34

    Article  PubMed  CAS  Google Scholar 

  6. Griffin MR. Epidemiology of nonsteroidal anti-inflammatory drug-associated gastrointestinal injury. Am J Med 1998; 104(3A): 23S–9S

    Article  PubMed  CAS  Google Scholar 

  7. Elliott SL, Yeomans ND, Buchanan RRC, et al. Efficacy of 12 months’ misoprostol as prophylaxis against NSAID-induced gastric ulcers: a placebo controlled trial. Scand J Gastroenterol 1994; 23: 171–6

    CAS  Google Scholar 

  8. Langman MJS, Brooks P, Hawkey CJ, et al. Management of non-steroidal anti-inflammatory drug associated ulcer: epidemiology, causation and treatment. J Gastroenterol Hepatol 1991; 6: 442–9

    Article  PubMed  CAS  Google Scholar 

  9. Henry D, Lim LL, Garcia Rodriguez LA, et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. BMJ 1996; 312: 1563–6

    Article  PubMed  CAS  Google Scholar 

  10. Raskin JB, White RH, Jackson JE, et al. Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimens. Ann Intern Med 1995; 123: 344–50

    PubMed  CAS  Google Scholar 

  11. Silverstein FE, Graham DY, Senior JR, et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs: a randomised, double-blind, placebo-controlled trial. Ann Intern Med 1995; 123: 241–9

    PubMed  CAS  Google Scholar 

  12. Ehsanullah RSB, Page MC, Tildesley G, et al. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine. BMJ 1988; 297: 1017–21

    Article  PubMed  CAS  Google Scholar 

  13. Robinson MG, Griffin JW, Bowers J, et al. Effect of ranitidine on gastroduodenal mucosal damage induced by nonsteroidal antiinflammatory drugs. Dig Dis Sci 1989; 34: 424–8

    Article  PubMed  CAS  Google Scholar 

  14. Roth SH, Bennett RE, Mitchell CS, et al. Cimetidine therapy in nonsteroidal anti-inflammatory drug gastropathy: double-blind long-term evaluation. Arch Intern Med 1987; 147: 1798–801

    Article  PubMed  CAS  Google Scholar 

  15. Taha AS, Hudson N, Hawkey CJ, et al. Famotidine for the prevention of gastric and duodenal ulcers caused by non steroidal antiinflammatory drugs. N Engl J Med 1996; 334: 1435–9

    Article  PubMed  CAS  Google Scholar 

  16. Cullen D, Bardham KD, Eisner M, et al. Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users. Aliment Pharmacol Ther 1998; 12: 135–40

    Article  PubMed  CAS  Google Scholar 

  17. Ekström P, Carling L, Wetterhus S, et al. Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy — a Nordic multicentre study. Scand J Gastroenterol 1996; 31: 753–8

    Article  PubMed  Google Scholar 

  18. Bianchi Porro G, Imbesi V, Lazzaroni M, et al. Pantoprazole vs placebo in prevention of NSAID-induced ulcers [abstract]. Gastroenterology 1998; 114: A74

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Role of proton pump inhibitors in the prevention of NSAID-induced ulcers now emerging. Drugs Ther. Perspect 16, 6–10 (2000). https://doi.org/10.2165/00042310-200016120-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200016120-00002

Keywords

Search

Navigation